Literature DB >> 6983494

Minor histocompatibility antigen expression on F9 embryonal carcinoma cells revealed by T-cell mediated responses.

M C Simmler, P Avner, J P Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983494     DOI: 10.1007/BF00372306

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  14 in total

1.  Immunogenicity of mouse trophoblast and embryonic sac.

Authors:  R F Searle; E J Jenkinson; M H Johnson
Journal:  Nature       Date:  1975-06-26       Impact factor: 49.962

2.  Genetics of teratocarcinoma transplantation. II. Effect of a semidominant H-2-linked gene lying outside the immediate major histocompatibility complex on tumor formation by the embryonal carcinoma cell line F9 in H-2 congenic pairs.

Authors:  P Avner
Journal:  Transplantation       Date:  1980-09       Impact factor: 4.939

3.  Absence of significant H-2 and beta 2-microglobulin mRNA expression by mouse embryonal carcinoma cells.

Authors:  D Morello; F Daniel; P Baldacci; Y Cayre; G Gachelin; P Kourilsky
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

4.  Genetics of teratocarcinoma transplantation. III. Genetic control of resistance to F9 tumor formation in allogeneic hosts.

Authors:  P Avner; M C Simmler
Journal:  J Reprod Immunol       Date:  1982-02       Impact factor: 4.054

5.  Differential expression of minor histocompatibiility antigens on the surface of the mouse oocyte and preimplantation developmental stages.

Authors:  S Heyner; R D Hunziker; G L Zink
Journal:  J Reprod Immunol       Date:  1980-12       Impact factor: 4.054

6.  Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2.

Authors:  A Shedlovsky; L J Clipson; J L VandeBerg; W F Dove
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  Absence of H-2 antigens capable of reacting with cytotoxic T cells on a teratoma line expressing a T/t locus antigen.

Authors:  J Forman; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

8.  The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3.

Authors:  P R Avner; W F Dove; P Dubois; J A Gaillard; J L Guénet; F Jacob; H Jakob; A Shedlovsky
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

9.  Teratocarcinoma transplantation rejection loci: genetic localization of the Gt-1 locus on chromosome 17 and the expression of alternate alleles.

Authors:  A J Levine; A K Teresky
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Mouse cell-mediated lympholysis assay in serum-free and mouse serum-supplemented media: culture conditions and genetic factors.

Authors:  A B Peck; F H Bach
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

View more
  3 in total

1.  Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.

Authors:  S Ostrand-Rosenberg; V Clements
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

2.  MHC-unrestricted T-cell cytotoxicity against tumour cells.

Authors:  A M Sponaas; B Loveland; E Simpson
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

3.  Differential Hm antigen expression on EC cells and early differentiated derivatives.

Authors:  M C Simmler; P R Avner
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.